- Home
- PRTC vs SDHY Comparison
PRTC vs SDHY Comparison
Compare PRTC & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- SDHY
- Stock Information
- Founded
- PRTC 2015
- SDHY 2020
- Country
- PRTC United States
- SDHY United States
- Employees
- PRTC N/A
- SDHY N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- SDHY Finance/Investors Services
- Sector
- PRTC Health Care
- SDHY Finance
- Exchange
- PRTC Nasdaq
- SDHY Nasdaq
- Market Cap
- PRTC 402.3M
- SDHY 409.3M
- IPO Year
- PRTC N/A
- SDHY N/A
- Fundamental
- Price
- PRTC $16.74
- SDHY $15.64
- Analyst Decision
- PRTC Buy
- SDHY
- Analyst Count
- PRTC 1
- SDHY 0
- Target Price
- PRTC $45.00
- SDHY N/A
- AVG Volume (30 Days)
- PRTC 11.0K
- SDHY 94.0K
- Earning Date
- PRTC 04-28-2025
- SDHY 01-01-0001
- Dividend Yield
- PRTC N/A
- SDHY 8.46%
- EPS Growth
- PRTC N/A
- SDHY N/A
- EPS
- PRTC N/A
- SDHY 1.07
- Revenue
- PRTC $468,000.00
- SDHY N/A
- Revenue This Year
- PRTC N/A
- SDHY N/A
- Revenue Next Year
- PRTC $160.00
- SDHY N/A
- P/E Ratio
- PRTC N/A
- SDHY $14.31
- Revenue Growth
- PRTC N/A
- SDHY N/A
- 52 Week Low
- PRTC $13.30
- SDHY $13.93
- 52 Week High
- PRTC $32.98
- SDHY $15.50
- Technical
- Relative Strength Index (RSI)
- PRTC 47.62
- SDHY 41.11
- Support Level
- PRTC $13.30
- SDHY $15.01
- Resistance Level
- PRTC $16.75
- SDHY $15.86
- Average True Range (ATR)
- PRTC 0.98
- SDHY 0.43
- MACD
- PRTC -0.03
- SDHY -0.03
- Stochastic Oscillator
- PRTC 51.39
- SDHY 37.72
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.